RecruitingNot ApplicableNCT07146412

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study


Sponsor

HudsonAlpha Institute for Biotechnology

Enrollment

200 participants

Start Date

May 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Many individuals develop dementia, and dementia has multiple causes, yet we currently have limited treatment options. A critical observation of the effectiveness of the available dementia treatments is that they tend to be more effective when started early. Previous studies have shown that multimodal lifestyle interventions can significantly delay the onset of Alzheimer's dementia in individuals with high risk for Alzheimer's or with Mild Cognitive Impairment (MCI). These interventions may be less effective when initiated after dementia has already been diagnosed or is more advanced. This study has two primary goals. The first goal is to assess attitudes around dementia risk for participants throughout the study as they learn of their personalized risk and possible lifestyle factors that may modify that risk. The second goal is to serve as a logistical pilot for the implementation of data collection and processing and multimodal lifestyle intervention to reduce the risk factors of dementia in individuals without current cognitive impairment but who are at high risk of progression to dementia. Secondary goals of this study include better defining what factors contribute the most risk to dementia and identifying sub-types of dementia defined by different genetic and molecular risk factors.


Eligibility

Min Age: 65 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a lifestyle program designed to reduce dementia risk in older adults who have a family history of dementia. The program includes changes to diet, exercise, and mental activity, and researchers want to see if it lowers risk factors. **You may be eligible if...** - You are between 65 and 75 years old - At least one of your close biological relatives (parent, sibling) has had some form of dementia - Your cognitive screening score is normal (MoCA score above 24) - You can complete surveys and assessments in English - You have access to a computer, tablet, or smartphone with internet **You may NOT be eligible if...** - You have already been diagnosed with any form of cognitive impairment or dementia - You are unable or unwilling to complete physical tests or provide required samples Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMultimodal Lifestyle Intervention

The intervention supports adoption and maintenance of healthy behaviors including healthy nutrition The Mediterranean-DASH (Dietary Approaches to Stop Hypertension) Intervention for Neurodegenerative Delay, or MIND Diet), physical activity (150 min/week of moderate activity), stress management, weight management, and adherence to doctor-prescribed medical regimens. In addition, participants will be encouraged to participate regularly in social and learning activities, and to engage in cognitive training via Posit's BrainHQ web-based training tools (brainhq.com). Participants will be supported by telephone-based health coaching. Coaches will be currently licensed allied health providers such as Registered Dietitians. Using the combination of an individual's biological data (including genomics, blood, stool, saliva, etc.), activity data, behavioral data, and other incoming streams of health information, the coach will tailor the lifestyle intervention for each participant.


Locations(1)

Smith Family Clinic for Genomic Medicine

Huntsville, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07146412


Related Trials